Tu1458 AFIMKIBART NORMALIZES SERUM PROTEIN NETWORKS TOWARD HEALTHY CONTROL LEVELS IN ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B TUSCANY-2 TRIAL

Gastroenterology 2026

View at publisher
Authors: Sarah Chang, Allen Nguyen, Jeongsup Shim, Jessica Chen, Gizette V. Sperinde, Anindita Banerjee, Deepa E. Chandra, Elena Peeva, Srividya Neelakantan, Michael S. Vincent, Margaret Neighbors
DOI: 10.1016/s0016-5085(26)03146-x
Cited by: 1

Fields of Study & Subjects

Inflammatory Bowel Disease Microscopic Colitis Oral microbiology and periodontitis research

Publication details

Journal / source
Gastroenterology
Publisher
Elsevier BV
Volume
170
Issue
6
Pages
S–1256
Publication date
1 May 2026
Language
EN